SHIRA ALBERT: Open Payments
NPI 1063817831 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $140 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 1 | $98 |
| Lundbeck LLC | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Neuronetics, Inc. | 1 | $9 |
Products named: RECORLEV, REXULTI, XIFAXAN, CAPLYTA, NEUROSTAR TMS THERAPY SYSTEM.
Industry payments across WA — which companies pay providers there.
